Articles

  • 1 week ago | nbcchicago.com | Sarah Min |Pia Singh

    • Shares of Regencell Bioscience, a Hong Kong-based developer of traditional Chinese herbal treatments that it says can treat childhood ADHD and autism, more than tripled Monday. The stock soared more than 280% after a 38-for-1 stock split. • The company, which has no revenue, is up roughly 46,000% in 2025.

  • 1 week ago | cnbc.com | Sarah Min |Pia Singh

    This Cookie Notice (“Notice”) explains how NBCUniversal and its affiliates (“NBCUniversal” or “we”), along with our partners, including advertisers and vendors, use cookies and similar tracking technologies when you use our websites, applications, such as games, interactive TV, voice-activated assistants, and other services that link to this policy, as well as connected devices, including those used in our theme parks (“Services”).

  • 2 weeks ago | flipboard.com | Lisa Kailai Han |Pia Singh |Sean Conlon

    6 hours agoSpotify’s new HR leader masterminded her company’s remote work policy and gives one piece of key adviceSpotify has found a new HR leader: Anna Lundström. The native Swede and New York City dweller was appointed as CHRO of the music streaming giant in …6 hours agoI tried the Nintendo Switch 2.

  • 2 weeks ago | flipboard.com | Lisa Kailai Han |Pia Singh |Sean Conlon

    5 hours agoFloppy Disks and Windows 95: The FAA Needs New TechAir Traffic Control software reaches middle age. Remember the good ol’ days of Windows 95? No? That’s because Microsoft ended support for the …4 hours agoMalcolm in the Middle's Erik Per Sullivan Getting Master's Degree at Harvard UniversityMalcolm in the Middle’s Erik Per Sullivan, known for his role as Dewey on the series, is working on his master’s degree at Harvard University.

  • 3 weeks ago | cnbc.com | Pia Singh

    Investors should pick up shares of Shopify as the company continues to innovate in an increasingly AI-powered e-commerce industry, according to Wells Fargo. Analyst Andrew Bauch reiterated his overweight rating on Shopify shares and lifted his price target by $18 to $125, which suggests the stock has about 19% upside ahead.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
913
Tweets
371
DMs Open
Yes
No Tweets found.